Hyperlipidemia is very common in renal transplant recipients. The reason may be related to heredity, high-fat diet and immunosuppressant.
The latest research
The Tufts team recently published their findings on the link between hyperlipidemia and organ rejection in the American Journal of Transplantation. The findings suggest that hyperlipidemia (mainly triglyceride and high cholesterol) may increase the risk of rejection by regulating the immune system. Classical immunological theory does not link rejection to hyperlipidemia. This study found that hyperlipidemia can affect the levels of Th17 cells and Treg cells in the body and increase the risk of organ transplant rejection, which complements the relevant theories of organ transplant rejection. Points to note
This study shows that long-term follow-up after kidney transplantation, blood lipid testing is necessary. Hyperlipidemia not only damages the cardiovascular system, but also directly increases the risk of rejection! Pay attention to maintaining a healthy lifestyle, such as a low-fat diet, weight control, and exercise. When necessary, supplemented with lipid-lowering drugs. At present, the most commonly used oral lipid-lowering drugs in clinic are Lipitor, codine, servastatin, pralidoxime and so on. Dr. Jia concludes
Hyperlipidemia is a major adverse factor affecting the health of renal transplant recipients. In the past, we have focused on the adverse effects of the cardiovascular system, but the latest research shows that high blood lipids increase the risk of rejection. Therefore, it is very necessary for renal transplant patients to adhere to blood lipid detection, maintain a healthy lifestyle, and if necessary, supplement with lipid-lowering drugs to strictly control blood lipid levels.
Article | Jia Yichen, editor | Qi Guisheng, homepage image from the Internet
